A carregar...

Anti-GD2 Antibody Therapy for GD2-expressing Tumors

In the development of novel immune therapies for high-risk cancers, one goal is to find tumor targets that are not widely shared by normal cells. One such target is the surface disialoganglioside GD2. This antigen is expressed on the surface of a variety of tumors for which no curative therapies exi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Navid, Fariba, Santana, Victor M., Barfield, Raymond C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2888262/
https://ncbi.nlm.nih.gov/pubmed/20201786
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!